Patents Assigned to Biocontrol Technology, Inc.
-
Patent number: 6066406Abstract: The invention is directed to corrosion and wear resistant metallic coatings containing nickel and boron. The coatings are preferably deposited on catalytically active substrates from an electroless coating bath containing nickel ions, lead tungstate as a stabilizer, a metal ion complexing agent, and a borohydride reducing agent, at a pH of about 10 to about 14. With post-coating heat treatment the coated surfaces exhibit hardness levels as high as about 2200 Knoop.Type: GrantFiled: May 8, 1998Date of Patent: May 23, 2000Assignee: Biocontrol Technology, Inc.Inventor: Charles Edward McComas
-
Patent number: 5562729Abstract: A multi-leaflet (usually trileaflet) heart valve composed of biocompatible polymer which, in all of its embodiments, simultaneously imitates the structure and dynamics of biological heart valves and avoids promotion of calcification. The valve includes a plurality of flexible leaflets dip cast on a mandrel, which leaflets are then bonded with a bonding agent to the interior surfaces of a plurality of struts on a metal-reinforced prosthetic stent. The leaflets open and close in response to the pumping action of the heart and, due to the design of the leaflets, fatigue resistance of the heart valve is high. The leaflets and the polymer components of the prosthetic stent are manufactured of biocompatible polymers exhibiting intrinsic calcification-resistant properties.Type: GrantFiled: November 1, 1994Date of Patent: October 8, 1996Assignee: Biocontrol Technology, Inc.Inventors: David L. Purdy, James R. Cupp, Frederick J. Shipko, Robert D. Norman
-
Patent number: 5354277Abstract: A method for extracorporeal blood treatment which utilizes a hemodialysis machine capable of heating the dialysis fluids to 48.degree. C., a hollow-fiber, high efficiency hemodialyzer, and a tubular heat exchanger--in addition to various probes and catheters and heated anterior and posterior blankets for the patient--to effect extracorporeal treatment without adverse effect on blood physiology and without the need for general anesthesia.Type: GrantFiled: September 4, 1992Date of Patent: October 11, 1994Assignee: Biocontrol Technology, Inc.Inventors: Joseph A. Guzman, Miguel P. Cosio
-
Patent number: 5070874Abstract: Radiation in the near infrared over a limited range of wavelengths about 1660 nanometers is projected on a portion of the body, for example, the ear, of the patient. The resulting radiation emitted by the portion, either scattered from the portion or transmitted after absorption and scattered by the portion, is processed to derive an expression of the resulting radiation as a function of the wavelength. The second derivative of this function over a very narrow range of this function between 1640 and 1670 nanometers is expanded and the glucose concentration is determined from the magnitude, or intensity, of the scattered or transmitted radiation at the maximum or minimum point of this derivative apparatus for non-invasive determination of glucose concentration in the patient. Radiation in the near infrared is transmitted through a first fiber-optic radiation conductor to the outer surface of a portion of the patient's body, penetrating into the portion.Type: GrantFiled: January 30, 1990Date of Patent: December 10, 1991Assignee: Biocontrol Technology, Inc.Inventors: Russell H. Barnes, Jimmie W. Brasch, Sr., David L. Purdy
-
Patent number: 4907593Abstract: A rate-changing implantable heart-stimulating device is disclosed, one that avoids use of moving parts and making unwanted rate changes. The device senses and responds to skeletal myopotential signals derived from the body of the wearer, preferably considering both amplitude and frequency of myopotential voltage signals which exceed a predetermined threshold value. The device preferably has two-way radio communication with an external programmer means.Type: GrantFiled: May 21, 1987Date of Patent: March 13, 1990Assignee: Biocontrol Technology, Inc.Inventors: Charles M. Rapach, David L. Purdy, Orlando Maytin
-
Patent number: 4892518Abstract: Hemodialysis port assembly including a port and a catheter assembly. The port includes an inlet septum subtended by an inlet plenum and an outlet septum subtended by an outlet plenum. The catheter assembly includes an inlet channel connected to the inlet plenum and an outlet channel connected to the outlet plenum. The port and catheter assembly are completely implanted in the chest of a patient with the port subcutaneous and the end of the catheter assembly remote from the port injected into the subclavian vein. The blood flow in this vein is in the direction away from the end of the catheter assembly. Near this remote end the catheter assembly or the inlet channel terminates in an inlet valve and the outlet channel terminates in an outlet valve. Each of these valves is essentially a flapper on which the blood is incident in a generally perpendicular direction so that its flow is substantially unimpeded.Type: GrantFiled: December 4, 1987Date of Patent: January 9, 1990Assignee: Biocontrol Technology, Inc.Inventors: James R. Cupp, Robert D. Norman, David L. Purdy, Orlando Maytin